HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong Suk Song Selected Research

orantinib (SU6668)

12/2017Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.
4/2016Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
8/2014Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.
6/2014A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong Suk Song Research Topics

Disease

19Neoplasms (Cancer)
01/2019 - 03/2005
17Stomach Neoplasms (Stomach Cancer)
01/2019 - 08/2004
7Adenocarcinoma
08/2015 - 12/2005
5Breast Neoplasms (Breast Cancer)
12/2017 - 08/2014
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2017 - 06/2008
4Neutropenia
01/2019 - 01/2014
4Pain (Aches)
07/2012 - 01/2003
3Disease Progression
01/2019 - 09/2009
3Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2017 - 03/2010
3Pancreatic Neoplasms (Pancreatic Cancer)
08/2015 - 10/2008
2Nausea
01/2019 - 01/2014
2Vomiting
01/2019 - 01/2014
2Colorectal Neoplasms (Colorectal Cancer)
07/2017 - 06/2014
2Neoplasm Metastasis (Metastasis)
07/2017 - 03/2005
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
06/2014 - 04/2012
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2013 - 03/2009
2Diarrhea
12/2012 - 01/2008
2Cancer Pain
07/2012 - 01/2011
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2010 - 07/2010
2T-Cell Lymphoma (Lymphoma, T Cell)
09/2006 - 02/2006
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Anemia
01/2019
1Prostatic Neoplasms (Prostate Cancer)
10/2018
1Carcinogenesis
10/2018
1Acute Disease
01/2018
1Ascites
01/2018
1Ovarian Neoplasms (Ovarian Cancer)
09/2017
1Ovarian Epithelial Carcinoma
09/2017
1Febrile Neutropenia
01/2017
1Thyroid Neoplasms (Thyroid Cancer)
01/2015
1Second Primary Neoplasms (Neoplasms, Second)
01/2015
1Carcinoma (Carcinomatosis)
01/2014
1Dyspnea (Shortness of Breath)
12/2012
1Breakthrough Pain
07/2012
1Edema (Dropsy)
07/2010
1Blast Crisis (Blast Phase)
07/2010
1Esophageal Neoplasms (Esophageal Cancer)
05/2010
1Xeroderma Pigmentosum (Kaposi's Disease)
03/2010

Drug/Important Bio-Agent (IBA)

14Cisplatin (Platino)FDA LinkGeneric
05/2017 - 06/2005
8Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 06/2005
8Docetaxel (Taxotere)FDA Link
12/2017 - 05/2010
7GemcitabineFDA Link
05/2017 - 10/2008
5Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2015 - 07/2009
4orantinib (SU6668)IBA
12/2017 - 06/2014
4Imatinib Mesylate (Gleevec)FDA Link
04/2012 - 02/2006
3Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 12/2005
3Angiogenesis InhibitorsIBA
12/2017 - 08/2014
3PlatinumIBA
09/2017 - 12/2012
3Fluorouracil (Carac)FDA LinkGeneric
08/2015 - 03/2009
3ParaffinIBA
06/2014 - 09/2006
3DNA (Deoxyribonucleic Acid)IBA
06/2014 - 03/2010
2AnthracyclinesIBA
12/2017 - 08/2014
2Rituximab (Mabthera)FDA Link
06/2013 - 03/2009
2Analgesics (Analgesic Drugs)IBA
01/2011 - 01/2003
2ErbB Receptors (EGF Receptor)IBA
03/2010 - 09/2009
2Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2009 - 06/2008
2Pharmaceutical PreparationsIBA
09/2009 - 07/2009
2Proteins (Proteins, Gene)FDA Link
03/2005 - 08/2004
14- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA
10/2018
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2018
1Blood Proteins (Serum Proteins)IBA
01/2018
1RamucirumabIBA
01/2018
1Alkaline PhosphataseIBA
01/2018
1AlbuminsIBA
01/2018
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
09/2017
1GoldIBA
09/2017
1Immune Checkpoint InhibitorsIBA
09/2017
1NivolumabIBA
09/2017
1genexol-PMIBA
07/2017
1MicellesIBA
07/2017
1Carcinoembryonic AntigenIBA
07/2017
1cremophor ELIBA
07/2017
1EnzymesIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
04/2016
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
06/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014
1Ondansetron (Zofran)FDA LinkGeneric
01/2014
1azasetronIBA
01/2014
1Pemetrexed (MTA)FDA Link
12/2012
1Gefitinib (Iressa)FDA Link
12/2012
1Monoclonal AntibodiesIBA
08/2012
1Indicators and Reagents (Reagents)IBA
08/2012
1MucinsIBA
08/2012
1Formaldehyde (Formol)FDA Link
08/2012
1Oxycodone (Oxycontin)FDA LinkGeneric
07/2012
1Hydromorphone (Dilaudid)FDA LinkGeneric
07/2012
1Thymidylate SynthaseIBA
03/2010
1Epidermal Growth Factor (EGF)IBA
03/2010
1Cetuximab (Erbitux)FDA Link
03/2010

Therapy/Procedure

16Drug Therapy (Chemotherapy)
01/2019 - 12/2005
10Combination Drug Therapy (Combination Chemotherapy)
01/2017 - 06/2005
8Therapeutics
01/2019 - 07/2009
3Pain Management
06/2013 - 01/2003
3Palliative Care (Palliative Therapy)
01/2011 - 09/2009
2Aftercare (After-Treatment)
01/2015 - 09/2012
1Castration
10/2018
1Cytoreduction Surgical Procedures
09/2017
1Chemoradiotherapy
08/2015
1Consolidation Chemotherapy
08/2015
1Time-to-Treatment
07/2010